Activity Analyses of Staphylococcal Isolates From Pediatric, Adult, and Elderly Patients: AWARE Ceftaroline Surveillance Program

Sader, Helio S.; Flamm, Robert K.; Farrell, David J.; Jones, Ronald N.
September 2012
Clinical Infectious Diseases;Sep2012 Supplement 3, Vol. 55 Issue suppl_3, pS181
Academic Journal
Ceftaroline, the active metabolite of the prodrug ceftaroline fosamil, is a broad-spectrum cephalosporin with bactericidal activity against resistant Gram-positive organisms, including methicillin-resistant Staphylococcus aureus (MRSA), and common Gram-negative organisms. We evaluated the activity of ceftaroline and various antimicrobial agents against S. aureus isolates according to patient age. A total of 2143 consecutive unique patient strains of clinical significance were collected between January and December 2010 from 65 US medical centers as part of the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) Program. Ceftaroline and various comparator agents were tested by reference Clinical and Laboratory Standards Institute broth microdilution methods. Ceftaroline was consistently active against methicillin-susceptible S. aureus (MSSA) (MIC50, 0.25 μg/mL; MIC90, 0.25 μg/mL; 100.0% susceptible) and MRSA (MIC50, 0.50 μg/mL, MIC90, 1 μg/mL; 98.4% susceptible) from all age groups. In general, resistance rates to erythromycin, clindamycin, and levofloxacin were higher in the population aged ≥65 years, whereas resistance rates to clindamycin and levofloxacin were lowest among isolates from patients aged 6–17 years. When tested against MSSA, levofloxacin resistance was higher among isolates from patients aged ≥65 years (16.1%) than among isolates from the other age groups (6.1%–10.5%), and ceftaroline was generally 16-fold more active than ceftriaxone (MIC50, 4 μg/mL; MIC90, 4 μg/mL; 97.9% susceptible overall). Ceftaroline (MIC50, 0.50 μg/mL; MIC/90, 1 μg/mL), daptomycin (MIC50, 0.25 μg/mL; MIC90, 0.5 μg/mL), linezolid (MIC50, 1 μg/mL; MIC90, 1 μg/mL), and vancomycin (MIC50, 1 μg/mL; MIC90, 1 μg/mL) were the most active compounds tested against MRSA strains, and the activity of these compounds did not vary significantly among the age groups. In contrast, susceptibility rates to clindamycin and levofloxacin varied from 94.0% and 60.7% (aged 6–17 years), respectively, to only 57.6% and 15.1% (aged ≥65 years), respectively, among MRSA strains. The results of this study showed major differences in the susceptibility rates to clindamycin and levofloxacin according to patient age group. The results also indicate that ceftaroline is highly active against MSSA and MRSA isolated from US medical centers, independent of patient age group.


Related Articles

  • Profile of Methicillin-resistant Staphylococcus aureus Among Nursing Home Residents in Hawai'i. Fenfang Li; Arnsberger, Pamela; Miller, F. DeWolfe // Hawaii Medical Journal;May2010, Vol. 69 Issue 5, p126 

    Residing in long-term care facilities has long been identified as a risk factor for methicillin-resistant Staphylococcus aureus (MRSA) carriage and infection. The objective of this study was to describe MRSA epidemiology among residents in skilled nursing and intermediate care facilities...

  • Ceftaroline: A New Cephalosporin with Activity Against Methicillin-Resistant Staphylococcus aureus (MRSA). Duplessis, Christopher; Crum-Cianflone, Nancy F. // Clinical Medicine Reviews in Therapeutics;2011, Vol. 3, p1 

    Microbial resistance has reached alarming levels, threatening to outpace the ability to counter with more potent antimicrobial agents. In particular, methicillin-resistant Staphylococcus aureus (MRSA) has become a leading cause of skin and soft-tissue infections and PVL-positive strains have...

  • Frecuencia de portadores nasales de Staphylococcus aureus resistente a meticilina en personal de salud de hospitales de Nicaragua. Cáceres, Mercedes // Pan American Journal of Public Health;Dec2011, Vol. 30 Issue 6, p610 

    Objective. To determine the frequency of nasal carriers of strains of methicillin-resistant Staphylococcus aureus (MRSA) and the antimicrobial resistance pattern of these strains, obtained from health workers from four hospitals in Nicaragua. Methods. A descriptive cross-sectional study was...

  • Cleaning Up the Farm. BLACK, JANE // Prevention;Mar2014, Vol. 66 Issue 3, p102 

    The article discusses the worsening antibiotic resistance in the U.S. as 2 million people in the U.S. get infections resistant to antibiotics every years with at least 23,000 people dying as a result. It points out that dozens of new, virulent bacteria have emerged over the years including...

  • Forever Unprepared � The Predictable Unpredictability of Pathogens. Sepkowitz, Kent A. // New England Journal of Medicine;7/9/2009, Vol. 361 Issue 2, p120 

    The author offers insights on the predictable unpredictability of the pathogens methicillin-resistant Staphylococcus aureus (MRSA) and the pre-swine edition of influenza virus. He warns about the spread of community-acquired MRSA into hospitals and clinics and the appearance of...

  • Is It Time to Replace Vancomycin in the Treatment of Methicillin-Resistant Staphylococcus aureus Infections? van Hal, Sebastiaan J.; Fowler, Vance G. // Clinical Infectious Diseases;Jun2013, Vol. 56 Issue 12, p1779 

    The role of vancomycin has been challenged by the availability of alternative antibiotics, increased reports of vancomycin failure, and uncertainties in dosing. This manuscript considers the optimal treatment of methicillin-resistant Staphylococcus aureus infections.For more than 4 decades,...

  • Detection of inducible clindamycin resistance (MLSBi) among methicillin-resistant Staphylococcus aureus (MRSA) from Libya. Ahmed, Mohamed O.; Alghazali, Mohamed H.; Abuzweda, Abdelalbaset R.; Amri, Samira G. // Libyan Journal of Medicine;Mar2010, Vol. 5 Issue 5, p1 

    The article presents a study which examines methicillin-resistant Staphylococcus aureus (MRSA) collected isolates to detect inducible clindamycin resistance (MLSBi) in Libya. The study found 128 MRSA isolates as Staphylococcus aureus and researchers tested them against erythromycin, clindamycin...

  • Cfr-mediated linezolid resistance in methicillin-resistant Staphylococcus aureus and Staphylococcus haemolyticus associated with clinical infections in humans: two case reports. Feßler, Andrea T.; Calvo, Noelia; Gutiérrez, Nieves; Muñoz Bellido, Juan Luis; Fajardo, Miguel; Garduño, Eugenio; Monecke, Stefan; Ehricht, Ralf; Kadlec, Kristina; Schwarz, Stefan // Journal of Antimicrobial Chemotherapy (JAC);Jan2014, Vol. 69 Issue 1, p268 

    This article describes two cases which detected the multiresistance gene cfr in methicillin-resistant Staphylococcus aureus and Staphylococcus haemolyticus from patients with septic shock. Investigators characterized the Staphylococcus strains and investigated for the genetic basis of linezolid...

  • Changing needs of community-acquired pneumonia. Ramirez, Julio Alberto; Anzueto, Antonio R. // Journal of Antimicrobial Chemotherapy (JAC);Apr2011 Supplement 3, Vol. 66 Issue suppl_3, piii3 

    Community-acquired pneumonia (CAP) is a serious condition associated with significant morbidity and potential long-term mortality. Although the majority of patients with CAP are treated as outpatients, the greatest proportion of pneumonia-related mortality and healthcare expenditure occurs among...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics